David Wilson
Profile
Mr. David Wilson is a Manager-Business Development at HiberGene Diagnostics Ltd.
Mr. Wilson was previously employed as a Principal by Boehringer Mannheim Diagnostics Corp., a Principal by Genzyme Corp., a Principal by Vitro Diagnostics, Inc., and Vice President-European Commercial Operations by Molecular Detection, Inc.
He received his undergraduate degree from the University of St. Andrews and an MBA from The Open University.
Former positions of David Wilson
| Companies | Position | End |
|---|---|---|
HiberGene Diagnostics Ltd.
 HiberGene Diagnostics Ltd. Medical/Nursing ServicesHealth Services HiberGene Diagnostics Ltd. develops, manufactures, and markets molecular diagnostic tests for human infectious diseases. Its products include Loop Mediated Isothermal Amplification (LAMP) technology, HG swift, HG meningococcus, pipeline, and HG group B streptococcus. The company was founded by Brendan K. Farrell, Peter William Kidney, Peter Valentine Coyle, Derek J. Fairley, and Joe Kidney in November 2009 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | - |
Boehringer Mannheim Diagnostics Corp.
 Boehringer Mannheim Diagnostics Corp. Medical SpecialtiesHealth Technology Part of Roche Holding AG, Boehringer Mannheim Diagnostics Corp. develops and manufactures personal diagnostic devices. The company is based in Houston, TX. | Corporate Officer/Principal | - |
| VITRO DIAGNOSTICS, INC. | Corporate Officer/Principal | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Molecular Detection, Inc.
 Molecular Detection, Inc. Medical SpecialtiesHealth Technology Molecular Detection, Inc. develops and commercializes molecular diagnostic tests to detect infectious diseases. It offers Detect-Ready methicillin-resistant Staphylococcus aureus (MRSA) panel that allows for the detection of MRSA. The company was founded by Aryeh L. Gassel in 2007 and is headquartered in Wayne, PA. | Corporate Officer/Principal | - |
Training of David Wilson
| The Open University | Masters Business Admin |
| University of St. Andrews | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Private companies | 5 |
|---|---|
Molecular Detection, Inc.
Molecular Detection, Inc. Medical SpecialtiesHealth Technology Molecular Detection, Inc. develops and commercializes molecular diagnostic tests to detect infectious diseases. It offers Detect-Ready methicillin-resistant Staphylococcus aureus (MRSA) panel that allows for the detection of MRSA. The company was founded by Aryeh L. Gassel in 2007 and is headquartered in Wayne, PA. | Health Technology |
Vitro Biopharma, Inc.
 Vitro Biopharma, Inc. Chemicals: Major DiversifiedProcess Industries Vitro Biopharma, Inc. develops and commercializes adult stem cell technology for applications in stem cell research, drug development and therapeutic products for treatment a vast variety of diseases and conditions. Its products include cell culture media, cell lines, and nutravivo-dietary-supplements. The company was founded by James R. Musick on March 31, 1986 and is headquartered in Denver, CO. | Process Industries |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Boehringer Mannheim Diagnostics Corp.
Boehringer Mannheim Diagnostics Corp. Medical SpecialtiesHealth Technology Part of Roche Holding AG, Boehringer Mannheim Diagnostics Corp. develops and manufactures personal diagnostic devices. The company is based in Houston, TX. | Health Technology |
HiberGene Diagnostics Ltd.
HiberGene Diagnostics Ltd. Medical/Nursing ServicesHealth Services HiberGene Diagnostics Ltd. develops, manufactures, and markets molecular diagnostic tests for human infectious diseases. Its products include Loop Mediated Isothermal Amplification (LAMP) technology, HG swift, HG meningococcus, pipeline, and HG group B streptococcus. The company was founded by Brendan K. Farrell, Peter William Kidney, Peter Valentine Coyle, Derek J. Fairley, and Joe Kidney in November 2009 and is headquartered in Dublin, Ireland. | Health Services |
- Stock Market
- Insiders
- David Wilson
